baber/WOPTO huggingface dataset:
Patent AU-702001-B2 (AU)
Title: Atomizer
Inventor: DENYER JOHN STANLEY HAROLD
IPC: A61M11/06
Filed: 1995-11-10
Granted: 1999-02-11
Abstract: An atomizer including a gas exit, an outlet adjacent the gas exit, and a deflector for deflecting gas issuing from the gas exit over the outlet for drawing a substance to be atomized out from one outlet and atomizing the substance in the gas issuing from the gas exit characterised in that the deflector is movable between a first position in the path of the gas issuing from the gas exit for atomization and a second and non-atomizing position. <IMAGE>
Patent AU-703424-B2 (AU)
Title: Milk product
Inventor: MANDL HANS
IPC: A23L23/00
Filed: 1995-11-16
Granted: 1999-03-25
Abstract: A food is a milk prod. contg. at least 3% (at least 5%) of fat and at least 0.1% of gelatine.
Patent AU-758302-B2 (AU)
Title: System and method for pushing information from a host system to a mobile data communication device
Inventor: MOUSSEAU GARY P
IPC: G06F17/30
Filed: 1999-05-28
Granted: 2003-03-20
Abstract: A system and method for pushing information from a host system to a mobile data communication device upon sensing a triggering event is disclosed. A redirector program operating at the host system enables a user to continuously redirect certain user-selected data items from the host system to the user's mobile data communication device upon detecting that one or more user-defined triggering events has occurred. The redirector program operates in connection with event generating applications and repackaging systems at the host system to configure and detect a particular user-defined event, and then to repackage the user-selected data items in an electronic wrapper prior to pushing the data items to the mobile device.
Patent AU-612882-B2 (AU)
Title: Self-sealing valve for non-latex balloon
Inventor: KIEVES GARRY
IPC: A63H27/10
Filed: 1989-06-14
Granted: 1991-07-18
Abstract: The present invention relates to a self-sealing flexible plastic valve (10) for a non-latex balloon (12). The valve includes a positioning tab and a bonding barrier (76) at the inlet (64) end to facilitate automated insertion of the valve into the balloon.
Patent AU-621661-B2 (AU)
Title: T helper cell growth factor
Inventor: SNICK JACQUES VAN
IPC: C07K14/52
Filed: 1989-09-19
Granted: 1992-03-19
Abstract: The present invention relates generally to a T cell growth factor. More particularly, the present invention relates to a T cell growth factor which comprises a glycoprotein which supports interleukin 2- and interleukin 4-independent growth of helper T cells especially from murine and human sources and further which is capable of augmenting proliferation of IL3- or IL4-responsive cells. Even more particularly, the present invention relates to the helper T cell growth factor P40, pharmaceutical compositions thereof, antibodies thereto and recombinant DNA clones thereof. The present invention also contemplates a method for inducing the proliferation of helper T cells as well as IL3- and Il4-responsive cells. The helper T cells growth factor contemplated herein is useful in the stimulation of specific cells in the immune system, either alone or in combination with IL3 or IL4.
Patent AU-761308-B2 (AU)
Title: Analytical method using multiple virus labelling
Inventor: WILSON STUART MARK
IPC: C12Q1/70
Filed: 1999-06-04
Granted: 2003-06-05
Abstract: The present invention relates to a method for detecting a target material in a sample, which method comprises the steps of: a) exposing a sample, expected to contain that target material, to at least two viruses which are capable of binding directly or indirectly with that target material so as to form a virally bound target material and to endow the virally bound target material with a distinctive property; and b) cultivating the product from stage a in the presence of an indicator material to which the viruses carried by the virally bound target material attach so as to cause the indicator material to adopt the distinctive property of the virally bound target material; and c) monitoring the presence or otherwise of virally attached indicator material. The invention also provides a kit for use in the method of the invention.
Patent AU-756969-B2 (AU)
Title: Expandable preformed structures for deployment in interior body regions
Inventor: SCRIBNER ROBERT M
IPC: A61F2/44
Filed: 1999-06-01
Granted: 2003-01-30
Abstract: An expandable structure made from an elastomer material is preformed to a desired geometry by exposure to heat and pressure. The structure undergoes controlled expansion and further distention in cancellous bone, with controlled deformation and without stress failure.
Patent AU-678379-B2 (AU)
Title: Inhalation powder containing antistatic agent
Inventor: SIMPKIN GORDON THOMAS
IPC: A61K47/06
Filed: 1993-08-13
Granted: 1997-05-29
Abstract: A powder composition for inhalation comprising at least one microfine drug and a carrier, in which at least a portion of the said carrier comprises an antistatic agent.
Patent AU-750819-B2 (AU)
Title: Photogeneration of amines from alpha-aminoacetophenones
Inventor: BIRBAUM JEAN-LUC
IPC: C08K5/37
Filed: 1997-12-09
Granted: 2002-07-25
Abstract: Compounds of formula I, II or III X is a divalent radical; Y is C1-C6 aklylene, cyclohexylene or a direct bond; Ar1 is an aromatic radical as defined in claim 1, R1 and R2 are each independently the other, inter alia, a radical of formula in which p is zero or 1, or a radical of formula R3 is, inter alia, hydrogen, C1-C12alkyl, C5-C12cycloalkyl or phenyl-C1-C3alkyl; R4 is, inter alia, C1-C12cycloalkyl, phenyl-C1-C3alkyl or phenyl; or an acid addition salt of a compound of formula I, II or III; are useful as photosensitive base catalysts in base crosslinking compositions.
Patent AU-710918-B2 (AU)
Title: Method for enhancing the bulk softness of tissue paper and product therefrom
Inventor: TROKHAN PAUL DENNIS
IPC: D21H17/05
Filed: 1996-01-26
Granted: 1999-09-30
Abstract: Tissue paper having an enhanced bulk softness through incorporation of an effective amount of a polyhydroxy compound is disclosed. Preferably, from about 0.1% to about 2.0% of the polyhydroxy compound, on a dry fiber weight basis. These nonionic compounds have high rates of retention when applied to wet tissue paper webs according to the process described herein. Tissue embodiments of the present invention may further comprise a quantity of strength additive, such as starch, to increase paper strength.
Patent AU-629298-B2 (AU)
Title: N-substituted aminoalkanediphosphonic acids
Inventor: JAEGGI KNUT A
IPC: A61P3/00
Filed: 1990-02-16
Granted: 1992-10-01
Abstract: Compounds of the formula I   <IMAGE> (I)  in which R1 is an aromatic radical, n is 0, 1, 2 or 3, X is an oxy group, a thio group which can be oxidized or an imino group which is unsubstituted or has aliphatic substituents, alk1 and alk2 are identical or different divalent aliphatic radicals, and R2 is hydrogen or a monovalent aliphatic radical and salts thereof have properties which regulate calcium metabolism and can be employed for the treatment of diseases connected with disturbances in this metabolism. They are prepared, for example, by reacting a compound of the formula   <IMAGE> (V)  in which X3 is carboxyl with a phosphorylating agent and hydrolysing the primary product.
Patent AU-633878-B2 (AU)
Title: Protective device for gas pressure vessels
IPC: A62C3/00
Filed: 1990-03-06
Granted: 1993-02-11
Abstract: The protective device against an overheating, in particular by fire, of individual or batteries of pressure vessels (10) of a length (1) of at least 1.5 m serves for the storage and/or transportation of high- pressure gases. The pressure vessels (10) have at least one end cap (14) with a valve (18) or an end plug (20) with a melting plug (22) of an alloy melting at a low temperature. On at least one end cap (14) a pressure pipe (24), communicating constantly with the interior of a pressure vessel (10) branches off, which pressure pipe is led in axial direction (A) along at least a part of the pressure vessel (10). At intervals (a), essentially T-shaped fittings (26) are installed in the pressure pipe (24), which fittings have in their branching-off leg a melting plug (22) of an alloy melting at a low temperature. A blindly ending pressure pipe (24) is closed off by such a melting plug (22). The protective device is primarily used on pressure vessels of aluminium, in particular with a fibre-reinforced jacketing (12).
Patent AU-636608-B2 (AU)
Title: Tumor necrosis factor binding protein II, it's purification and antibodies thereto
IPC: C12P21/00
Filed: 1990-05-17
Granted: 1993-05-06
Abstract: Tumor Necrosis Factor (TNF) Binding Protein is isolated and substantially purified. It has the ability to inhibit the cytotoxic effect of TNF and/or to maintain its prolonged beneficial effects. TNF Binding Protein II and salts, functional derivatives, precursors and active fractions thereof can be used to antagonize the deleterious effects of TNP and to prolong its beneficial effects Polyclonal and monoclonal antibodies to the TNF Binding Protein II are produced. They be used as pharmaceutical agents and in diagnostic assays.
Patent AU-600667-B2 (AU)
Title: Vectors for the expression and secretion of hirudin by transformed yeasts
Inventor: LOISON GERARD
IPC: C12P/
Filed: 1986-05-02
Granted: 1990-08-23
Abstract: Functional block of DNA enabling to prepare hirudine from yeast, characterized in that it comprises at least: - the gene of hirudine or one of its variants (gene H); - A DNA sequence (Str) comprising the signals providing for the transcription of the gene H by the yeast.
Patent AU-591680-B2 (AU)
Title: Preventive drugs for elastosis
Inventor: HATAE SHINIKICHI
IPC: A61K31/35
Filed: 1986-06-16
Granted: 1989-12-14
Abstract: Drugs containing, as an effective ingredient, kojic acid or kojic acid/β-cyclodextrin inclusion complex have proved very effective in preventing elastosis in an animal test using Spraguex-Dawley rats. The drugs also have powerful action to inhibit the formation of melanin, and show an outstanding color fading effect in a culture test using mouse melanoma B16 cells. The drugs have very low toxicity and are externally applied in the form of an ointment, cream, emulsion, pack or solution.
Patent AU-676009-B2 (AU)
Title: Container closure device
Inventor: CARVALHEIRO JOSE
IPC: B29L31/56
Filed: 1994-02-09
Granted: 1997-02-27
Abstract: A closure device for a recipient with a threaded neck. It includes a tapped closure having a lower part attached to a guarantee strip by a zone of connection of low mechanical resistance, the strip presenting an elastically-deformable, inner, annular bead adapted to clip beneath a holding flange formed on a lower periphery of the neck by forced screwing of the closure; and an outer peripheral boss axially separated from the bead by a zone of controlled elastic deformation, an upper face of the boss and a lower edge of a lateral wall of the closure having formed therein, respectively, at least one tooth and at least one notch, the tooth being intended to be temporarily received in the notch during screwing when the bead is in abutment with the holding flange in order to avoid any relative rotational displacement of the closure with respect to the strip and to ensure clipping without deteriorating the zone of connection.
Patent AU-642657-B2 (AU)
Title: Rapid, versatile and simple system for expressing genes in eukaryotic cells
Inventor: MOSS BERNARD
IPC: C12N15/85
Filed: 1990-07-03
Granted: 1993-10-28
Abstract: An efficient, versatile and simple expression system which confers cap-independent translation to prokaryotic RNAs in eukaryotic cells has been described. The utility of recombinant vaccinia virus for this purpose has been illustrated.
Patent AU-704471-B2 (AU)
Title: Load monitoring device
Inventor: WOLTER FRANK-DIETRICH
IPC: G01L5/04
Filed: 1996-07-25
Granted: 1999-04-22
Abstract: The device has a base body with a part which deforms elastically until a threshold load is reached, above which it deforms plastically. An indication element is displaced from an initial position into a load indication position under spring action when deformation occurs, and remains in the load indicating position if the load is removed. The indication device is at least one sprung pivot lever (10,11) or a pivot lever subjected to spring action. The free end (8,9) of the pivot lever has at least one associated latching stop (5,7). The latching stop releases the pivot lever when a defined degree of deformation of the deformation part (2,3) of the base body (1) is reached.
Patent AU-755510-B2 (AU)
Title: Glyoxal as fuel additive
Inventor: KIEF HORST
IPC: C10L1/10
Filed: 1999-09-20
Granted: 2002-12-12
Abstract: Glyoxal in an aqueous solution is used in a fuel additive in order to reduce pollutants in the exhaust gases of gasoline and diesel engines. It is sufficient to add glyoxal in aqueous solution to gasoline in the dilution in the ratio of 1:1.000 to 1:20.000 and higher in order to obtain a reduction of unburned hydrocarbons and carbon monoxide in vehicles with catalytic converters at idle and at increased idle of almost 100 %. Esterified aliphats and polyethyleneglycol are added as emulsifiers and solubilizers. Additionally, glyoxal can be used in form of its acetals and hemiacetals with the resultant product being added to the fuel in combustion engines in order to reduce the pollutant emission and carbon particles/deposits.
Patent AU-682344-B2 (AU)
Title: Recombinant poxvirus and streptococcal M protein vaccine
Inventor: FISCHETTI VINCENT A
IPC: C07K14/315
Filed: 1994-05-12
Granted: 1997-10-02
Abstract: Viruses of the family poxviridae such as vaccinia or fowlpox viruses are modified to contain a gene which expresses a protein corresponding to the conserved exposed region of the M6 protein. The modified products are useful as vaccines against streptococcal infection.
Patent AU-677832-B2 (AU)
Title: Hitless switch arrangement
Inventor: GURTLER MICHAL O
IPC: H04J3/06
Filed: 1994-05-26
Granted: 1997-05-08
Abstract: The clock supply in large-scale systems with synchronous digital signal processing, for example in an SDH switching distributor, is designed as redundant in order to prevent operational system failure in the event of local failures or interruptions. The problem lies in completing the transition, without interference, from the defective clock pulse train to a different equivalent clock pulse train which has a different phase relation. A phase-locked loop generates the pulse train which is to be output. The phase shift is prevented by a changeover within the phase-locked loop, more precisely the control voltage of the PLL, in conjunction with a plurality of phase-shift compensation circuits (33, 34), one of which in each case constitutes the first part of the PLL. The phase-shift compensation circuit (33, 34) essentially comprises the phase discriminator of the PLL, supplemented by an adjustable delay and a correction voltage which can be readjusted. If the circuit is inserted in the PLL, the delay and the correction voltage remain set at the last determined value. The changeover is carried out in a virtually floating manner and essentially without phase change and without a transient effect. A frame insertion circuit (41) together with a frame monitor in the phase-shift compensation circuit enable the phase-exact processing of modulated clock pulse trains and open-circuit operation if all clock presettings fail. <IMAGE>
Patent AU-776433-B2 (AU)
Title: Luminous glucose monitoring device
Inventor: FENDROCK CHARLES
IPC: A61B5/145
Filed: 2000-07-28
Granted: 2004-09-09
Abstract: A glucose monitoring device suitable for use in total darkness or in limited light environment. The glucose monitoring device comprises a housing, which encloses the components of the device that determine the blood glucose level of a blood sample on a test strip. The exterior surface of the housing comprises a phosphorescent material. The portion of the test strip where the blood sample is to be applied can be illuminated by a light. The area of the glucose monitoring device where the test strip is inserted into the device can also be illuminated by a light. The display of the device, i. e., the area of the glucose monitoring device where the result is read, is also illuminated by a light.
Patent AU-675535-B2 (AU)
Title: Rotating particle separator with non-parallel separating ducts, and a separating unit
Inventor: BROUWERS JOZEF JOHANNES HUBERT
IPC: B01D45/14
Filed: 1994-04-15
Granted: 1997-02-06
Abstract: PCT No. PCT/NL94/00079 Sec. 371 Date Feb. 22, 1996 Sec. 102(e) Date Feb. 22, 1996 PCT Filed Apr. 15, 1994 PCT Pub. No. WO94/23823 PCT Pub. Date Oct. 27, 1994The invention relates to a separating body which can be set into rotation to separate solid or liquid particles of micron or submicron size from a fluid, wherein the body has a large number of separating ducts with singly connected walls over a substantial part of the axial length, where the walls of at least one of the separating ducts are not parallel to the axis of rotation. The tangent of the angle between the tangent planes of the walls of the separating duct and the axis of rotation is designated with tan  alpha , the radial width of the separating duct is designated with d, the length of the separating duct is designated with L and the rotation speed of the separating body is designated with  OMEGA  where these variables are chosen in mutual dependence in a manner such that the dimensionless number ( OMEGA Ld tan  alpha )/ nu  is located over a substantial part of the separating duct in the range up to 192, wherein  nu  is the kinematic viscosity of the fluid. The invention further relates to a separating unit provided with at least two separating bodies.
Patent AU-716838-B2 (AU)
Title: Foodstuffs preserving packaging
Inventor: TIPLER KEITH CHARLES
IPC: B65D81/24
Filed: 1996-08-02
Granted: 2000-03-09
Abstract: PCT No. PCT/GB96/01887 Sec. 371 Date Nov. 6, 1998 Sec. 102(e) Date Nov. 6, 1998 PCT Filed Aug. 2, 1996 PCT Pub. No. WO97/06074 PCT Pub. Date Feb. 20, 1997A foodstuff preserving packaging comprising a packaging substrate having a layer of a bonding agent including at least one foodstuff preservative.
Patent AU-629427-B2 (AU)
Title: 2-aromatic-3-halobenzothiazepines
Inventor: BORCHERDING DAVID R
IPC: C07D281/10
Filed: 1990-11-14
Granted: 1992-10-01
Abstract: 2-Aromatic-3-HALObenzothiazepines are prepared by reaction of a 2,3-dihydro-2-aromatic-3-hydroxybenzothiazepine with a thionyl HALide. For example, di-cis-2-(4-methoxyphenyl)-2,3-dihydro-3-hydroxy-1,5-benzothiazepin-4( 5H)-one refluxed with thionyl chloride can prepare E-2-(4-methoxyphenyl)-3-chloro-1,5-benzothiazepin-4(5H)-one in 66 percent yield.
Patent AU-675536-B2 (AU)
Title: Secondary amines as antidiabetic and antiobesity agents
Inventor: DOW ROBERT L
IPC: A61K31/34
Filed: 1994-05-20
Granted: 1997-02-06
Abstract: PCT No. PCT/IB94/00117 Sec. 371 Date Dec. 14, 1995 Sec. 102(e) Date Dec. 14, 1995 PCT Filed May 20, 1994 PCT Pub. No. WO94/29290 PCT Pub. Date Dec. 22, 1994The present invention relates to compounds of the formula    <IMAGE>  I  having utility as hypoglycemic and antiobesity agents, methods for their use and pharmaceutical compositions containing them. The compounds of the present invention also possess utility for increasing lean meat deposition and/or improving lean meat to fat ratio in edible animals, i.e. ungulate animals and poultry.
Patent AU-673744-B2 (AU)
Title: Printing process, and print and processed article obtained thereby
Inventor: SHIROTA KOROMO
IPC: C09D11/328
Filed: 1994-07-07
Granted: 1996-11-21
Abstract: Disclosed herein is a printing process in which at least three inks are applied to a cloth according to an ink-jet system to conduct printing, which comprises at least three steps of:   (a) applying at least two of the inks to the cloth in such a manner that at least a part of the two inks overlap each other; (b) subjecting the cloth, to which the inks have been applied, to a heat treatment; and   (c) washing the heat-treated cloth, wherein the cloth is a cloth comprising fibers dyeable with disperse dyes, each of the inks comprises a specified coloring matter, a compound for dispersing the coloring matter and an aqueous liquid medium.
Patent AU-686627-B2 (AU)
Title: Contact lens inspection apparatus and lens mold for use in such apparatus
Inventor: SU KAI C
IPC: B29C39/26
Filed: 1994-07-15
Granted: 1998-02-12
Abstract: A lens mold includes first (1) and second mold (2) members respectively having a concave (3) surface and a convex surface (4) for defining therebetween a lens cavity. One of the first and second mold members is configured to mechanically engage a ring of excess lens material upon polymerization of the lens material. Alternately, one of the first and second mold members includes a material formed along the periphery of a lens cavity (5) which causes the ring of excess lens material thereto. Furthermore, one of the first and second mold members is formed of a relatively transparent plastic material and includes an outer surface having an optical finish to permit optical inspection of a lens located on one of the concave and convex surfaces. Alternately, one of the first and second mold members is formed of a relatively opaque plastic material and includes an inner surface having an optical finish to permit optical inspection of a lens located on one of the concave and convex surfaces. <IMAGE>
Patent AU-706056-B2 (AU)
Title: Immunotoxin containing a disulfide-stabilized antibody fragment
Inventor: PASTAN IRA
IPC: A61K47/48
Filed: 1996-10-11
Granted: 1999-06-10
Abstract: This invention provides for nucleic acids encoding immunotoxins comprising a Pseudomonas exotoxin (PE) that does not require proteolytic activation for cytotoxic activity attached to an Fv antibody fragment having a variable heavy chain region bound through at least one disulfide bond to a variable light chain region. The combination of a "disulfide-stabilized" binding agent fused to a PE that does not require proteolytic activation provides an immunotoxin having surprising cytotoxic activity.
Patent AU-704089-B2 (AU)
Title: Vapor sterilization using inorganic hydrogen peroxide complexes
Inventor: JACOBS PAUL T
IPC: A61L2/18
Filed: 1996-10-23
Granted: 1999-04-15
Abstract: An apparatus and process for hydrogen peroxide vapor sterilization of medical instruments and similar devices make use of hydrogen peroxide vapor released from an inorganic hydrogen peroxide complex. The peroxide vapor can be released at room temperature and atmospheric pressure; however, the pressure used can be less than 50 torr and the temperature greater than 86 DEG C to facilitate the release of hydrogen peroxide vapor. Preferred hydrogen peroxide complexes for use in the invention include Na4P2O7.3H2O2 and KH2PO4.H2O2. The heating rate can be greater than 5 DEG C. Optionally, a plasma can be used in conjunction with the vapor. <IMAGE>
Patent AU-718568-B2 (AU)
Title: Lipopolyamines as transfection agents and their pharmaceutical applications
Inventor: BYK GERARDO
IPC: C12N15/87
Filed: 1996-11-08
Granted: 2000-04-13
Abstract: Lipopolyamines useful for the transfection of nucleic acid and methods of preparation thereof are disclosed. The lipopolyamines are of general formula I, in which R4 comprises at least one C10-C22 aliphatic radical.
Patent AU-641770-B2 (AU)
Title: Dosage form to deliver an antiparkinson agent
Inventor: EDGREN DAVID EMIL
IPC: A61K31/475
Filed: 1991-05-01
Granted: 1993-09-30
Abstract: A dosage form is disclosed comprising an anti-Parkinson's disease drug for administering to a patient in need of anti-Parkinson's disease therapy.